Latest Gene Therapy News

[Articles] Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomiseREGN727 was well tolerated and achieved substantial further LDL-C reduction in patients with heterozygous familial hypercholesterolaemia and elevated LDL-C treated with high-dose statins, with or without ezetimibe. REGN727 has the potential to provid...

Canadian research team makes safe iPS cells by the millionsUniversity of Calgary researchers Derrick Rancourt, PhD, and Roman Krawetz, PhD, have perfected a new bioreactor technology that allows them to make millions of pluripotent stem cells much more quickly than ever before. “The even better news is, we...

Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The LancetPARIS and TARRYTOWN, New York, May 26, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase 2 trial of SAR236553/REGN727 (Study 1003, NTC01266876) in patients with heterozygous familial hypercholesterolemia (heFH). SAR236553/REGN727 is a subcutaneously administered, fully-human antibod...

Natural Treatment and Maintenance of Prostate Enlargement with New Thermobalancing Therapy Improves Men’s Well-being in Safety States Fine TreatmentFine Treatment recommends new Thermobalancing Therapy as successful natural solution for benign prostatic hyperplasia that is also the most cost-effective prostate treatment on the market. While long-term medication courses and BPH surgeries may cost thousands of dollars, the price of Dr. Allen’s Device for Prostate Treatment under $150 makes it widely affordable. London, UK (PRWEB) May 26, 2012...

Medical Practice Expert, Nitin Chhoda, Releases Updated List of Ways to Build Community Connections with Education DirectorsA community is more than a collection of people, homes and businesses. It’s a source of referrals, good will and organizations that can bolster business and provide referrals. Nitin Chhoda, international medical marketing specialist, noted that education directors are an essential community connection that many medical professionals are unaware. He’s released an updated list of ways medical pr...

Clinical Support Services Develops MTM Program Assessment GuideCMS has strengthened MTM program rules and regulations, so Medicare plans are urged to take a hard look at their offerings to ensure their compliance and success. Buffalo, NY (PRWEB) May 26, 2012 New Medication Therapy Management (MTM) program requirements outlined by the Centers for Medicare & Medicaid Services (CMS) will make delivering a successful and compliant MTM program more challengin...

Environmentalism and anti-science, how GMOs prove any ideological extremity leads to anti-scienceDenialism blog has a say about the schermozzle looming at the Rothamsted UK agricultural research unit about the organic farming protest mob Take the Flour Back's threat to sabotage legitimate science experiments:Today I read about two individuals who decided on political defections over perceived anti-science amongst their former political allies- one due to climate change, the other for anti-GMO...

Combo Of Heat Shock Protein Inhibitor And Hormonal Therapy Being Tested In Breast Cancer Clinical TrialPushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part of this system, heat shoc...

CHMP recommends perampanel, aclidinium bromideEMA's CHMP issued several positive opinions on Friday, including one backing approval of Fycompa perampanel from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) to treat partial-onset seizures in epilepsy patients. The committee also supported approval of Br...

Vertex's Cystic Fibrosis Drug Kalydeco Given Green Light By EU's Scientific Advisory PanelVertex's cystic fibrosis product Kalydeco is one of five new molecular entities given a positive opinion by Europe's Committee for Medicinal Products for Human Use on May 25, which also included Almirall's novel COPD therapy aclidinium and Novo Nordi...

Pacific Quest Announces New Clinician HiresPacific Quest Wilderness Therapy, an outdoor therapeutic program for struggling adolescents and young adults, announces the hiring of two new primary clinicians, Haley Robinson and Bridger Jensen Hilo, HI (PRWEB) May 25, 2012 Pacific Quest Wilderness Therapy is pleased to announce the addition of two new clinicians to our Ohana! Haley Robinson and Bridger Jensen will both be joining Pacific Quest...

Aspirin Safely Prevents Recurrence of Venous ThromboembolismThe adverse event profile of aspirin is acceptable, making it a good therapeutic choice for many patients with unprovoked venous thromboembolism who have finished anticoagulant therapy. Medscape Medical News

BioScrip to Present at Jefferies 2012 Global Healthcare ConferenceBioScrip (NASDAQ: BIOS) today announced that the Company will present at the Jefferies 2012 Global Healthcare Conference to be held at the Grand Hyatt in New York City on June 4-7, 2012. Richard M. Smith, President and Chief Executive Officer, will present on Monday, June 4, 2012 at 11:30 a.m. Eastern Daylight Time. Hai V. Tran, Senior Vice Presid...

Diabetes Drug Shown to Work in Blacks (CME/CE)PHILADELPHIA (MedPage Today) -- A first-of-its-kind study found that African Americans with type 2 diabetes significantly benefited from linagliptin (Tradjenta) therapy.

MDxHealth: Annual and Extraordinary General Shareholders’ MeetingRegulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Annual and Extraordinary General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Annual General Meeting, including th...

GSK receives positive opinion from European CHMP for pazopanib in the treatment of patients with certain advanced soft tissue sarcomasGlaxoSmithKline. plc (GSK) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for Votrient® (pazopanib) for the treatment of a...

Pancreatectomy OK without downstaging from therapy(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published online May 17 in Cancer.

Immune Therapy Tames Colitis Flares (CME/CE)SAN DIEGO (MedPage Today) -- Oral tacrolimus was as effective as intravenous cyclosporine A for controlling symptoms of refractory ulcerative colitis, a researcher said here.

Common therapies for basal cell carcinoma offer similar survival(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published online May 21 in the British Journal of...

Testosterone Replacement Has Health Benefits (CME/CE)ATLANTA (MedPage Today) -- Testosterone replacement therapy decreased the prevalence of the metabolic syndrome in men with low levels of the hormone, researchers found.

A.M. Vitals: Shrinking School Budgets Hit Nurse’s OfficeAlso: Researchers say they have identified a gene that's important for producing sperm, a potential target for contraceptive pills; and a study suggests metabolic factors may be more important than obesity in predicting heart-disease risk.

Overactive BAALC gene found in people with acute leukemiaA small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

In vivo selection of autologous MGMT gene-modified cells following reduced-intensity conditioning with BCNU and temozolomide in the dog model

Major Scientific Conference Convened to Review The Safety Of GMO CropsA major international conference scientific meeting titled “Risk Assessment in Agricultural Biotechnology” was held at the University of California, Davis. It was sponsored by the College of Agriculture, The National Association of Stat...

News and press releases: European Medicines Agency recommends first-in-class medicine for treatment of cystic fibrosisThe European Medicines Agency has recommended Kalydeco (ivacaftor), an orphan-designated medicine, for the treatment of cystic fibrosis in patients age 6 years and older who have a G551D mutation in the cystic fibrosis transmembrane regulator (CFTR)...

0 1 2 3 4 ›»

buy Gene Therapy market research data and corporate reports now Advertisement